Pasar al contenido principal

Contribución del reprogramado del metabolismo de aminoácidos y de la desregulación de las calpaínas a la activación de fibroblastos y la fibrosis miocárdica difusa en insuficiencia cardiaca

PI23/00068

•
Nombre agencia financiadora Instituto de Salud Carlos III
Acrónimo agencia financiadora ISCIII
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i en Salud
Año convocatoria 2023
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario FUNDACION INSTITUTO DE INVESTIGACION VALLE DE HEBRON
Centro realización INSTITUTO DE INVESTIGACION HOSPITAL UNIVERSITARIO VALLE DE HEBRON (VHIR)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 7
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Iron Deficiency Is Associated With Impaired Myocardial Reperfusion in ST-Segment-Elevation Myocardial Infarction, Influence of the Definition Used

  • Barrabés, José A.|||0000-0001-7062-6277
  • Inserte, Javier|||0000-0003-2283-3591
  • Castellote, Laura
  • Buera Surribas, Irene|||0000-0001-6110-2367
  • Milà Pascual, Laia|||0009-0007-4932-657X
  • Sambola, Antonia
  • Uribarri, Aitor|||0000-0002-6911-7480
  • Vidal Burdeus, María|||0000-0002-9823-5021
  • Aluja, David|||0000-0002-0448-9419
  • Delgado-Tomás, Sara
  • Tobías-Castillo, Pablo E.|||0000-0003-0304-6197
  • Calvo-Barceló, Maria
  • Guala, Andrea|||0000-0002-5006-8164
  • Rodríguez Palomares, José F.|||0000-0002-7229-9780
  • García del Blanco, Bruno|||0000-0002-4527-1600
  • Beneitez Pastor, David|||0000-0002-6541-6600
  • Ferreira-Gonzalez, Ignacio|||0000-0002-1208-5561
The role of iron deficiency (ID) in ST-segment-elevation myocardial infarction (STEMI) remains unclear. This study aimed to assess whether ID is associated with impaired myocardial reperfusion in STEMI and whether this association is affected by ID definition. We included 942 consecutive patients with STEMI successfully treated with primary percutaneous coronary intervention. ID was defined either as recommended by international guidelines or, alternatively, as ferritin <100 ng/mL, transferrin saturation <20%, or serum iron ≤13 μmol/L. In 595 patients, serum soluble transferrin receptor levels were measured. Impaired myocardial reperfusion was defined as lack of ST-segment resolution ≥50% 60 to 90 minutes after percutaneous coronary intervention. Results: ID prevalence varied across these definitions. Impaired reperfusion was present in 12.7% of patients without ID and 41.0% of those with ID defined by transferrin saturation <20% (P<0.001). This association was less pronounced for serum iron ≤13 μmol/L, weaker for guideline criteria, and absent for high (≥1.59 mg/L) soluble transferrin receptor levels or low ferritin. Transferrin saturation <20%, but not ferritin-based criteria, was associated with poorer clinical course and left ventricular function and higher in-hospital mortality and remained an independent predictor of impaired reperfusion after adjusting for baseline predictors and anemia. Conclusions: ID defined by transferrin saturation <20% is strongly related to impaired ST resolution and predicts a worse in-hospital outcome in patients with STEMI treated with primary percutaneous coronary intervention. The association of other ID criteria with myocardial reperfusion or with the clinical course is weaker or absent. The potential preventive or therapeutic strategies targeting ID in STEMI warrant further investigation.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Efficacy of a cysteine protease inhibitor compared with enalapril in murine heart failure models

  • Aluja, David
  • Delgado Tomás, Sara
  • Ferreira González, Ignacio
  • Barrabés, José A.
  • miro casas, elisabet
  • Ruiz Meana, Marisol
  • Rodriguez-Sinovas, Antonio
  • Benito, Begoña
  • Inserte, Javier
Cardiovascular medicine; Cell biology, Medicina cardiovascular; Biologia cel·lular, Medicina cardiovascular; Biología celular, Cysteine proteases calpains contribute to heart failure (HF), but it remains unknown whether their inhibition provides any benefit compared to standard pharmacological treatment for HF. Here, we characterize the pharmacological properties of NPO-2270 (NPO) as a potent inhibitor of cysteine proteases. Then, we describe that acute administration of NPO in rodent models of transient ischemia at the time of reperfusion reduces myocardial infarction, while its chronic oral administration attenuates adverse remodeling and cardiac dysfunction induced by ischemic and non-ischemic pathological stimuli more effectively than enalapril when given at the same dose. Finally, we provide evidence showing that the effects of NPO correlate with calpain inhibition and the preservation of the T-tubule morphology, due at least in part to reduced cleavage of the calpain substrate junctophilin-2. Together, our data highlight the potential of cysteine protease inhibition with NPO as a therapeutic strategy for the treatment of heart failure., This work was funded by Instituto de Salud Carlos III, Spain, through the projects AES PI20/01681 and AES PI23/00068; and the research network CIBERCV (CB16/11/00479), both cofunded by European Regional Development Fund; Sociedad Española de Cardiología (SEC/FEC-INV-BAS 22/013); Fundació la Marató de TV3 (FLMTV3/202321-30-31) and PERIS STL/484/2023. Long-Sheng Song is supported by the National Institutes of Health of USA.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Glycative Stress Disrupts the Mitochondrial-Lysosome Axis and Promotes Geroconversion in Aging Cardiomyocytes

  • Valiuška, Simonas
  • Rubeo, Chiara
  • Bonzon-Kulichenko, Elena
  • Nichtova, Zuzana
  • BOU-TEEN, DIANA
  • miro casas, elisabet
  • Inserte, Javier
  • Rodriguez-Sinovas, Antonio
  • Benito, Begoña
  • Ródenas-Alesina, Eduard
  • Ferreira-Gonzalez, Ignacio
  • Ruiz Meana, Marisol
Aging; Cardiomyocytes; Lipofuscin, Envejecimiento; Cardiomiocitos; Lipofuscina, Envelliment; Cardiomiòcits; Lipofuscina, Aging is a major risk factor for heart failure, yet the molecular mechanisms linking cardiac aging to the inflammatory pathophysiology of heart failure remain elusive. Mitochondrial dysfunction and defective organelle quality control are emerging hallmarks of the aging heart, but their biochemical underpinnings are poorly defined. Using comprehensive glycomics, we found that cardiac mitochondria from physiologically aged mice (≥ 20 months) are the major intracellular reservoirs of advanced glycation end products (AGEs), derived primarily from the chemical attack of some α-oxoaldehydes on proteins. This was associated with mild mitochondrial dysfunction and structural remodeling. Lysosomes in aged hearts were enlarged, more abundant, less acidic, and frequently loaded with lipofuscin. Notably, ~7% of cardiomyocytes showed proinflammatory senescence traits. In vitro, glycative stress in H9c2 myoblasts reproduced mitochondrial AGE buildup, dysfunction, and activation of the mitochondria–lysosome axis. However, AGE-modified mitochondria impaired lysosomal acidification and proteolysis, hindering mitophagic clearance and contributing to lipofuscin accumulation. This sequence of events ultimately led to proinflammatory senescence in a subset of cells. These findings identify mitochondrial AGE accumulation as a novel mechanism of sublethal nonsolved aging-associated stress that eventually triggers geroconversion in cardiomyocytes. This mechanism could facilitate the transition of the aging heart towards a failing phenotype., This study was funded by the Instituto de Salud Carlos III of the Spanish Ministry of Health through the projects FIS-PI22-00513, FIS PI23/00068, TACTICS (FORT23/0034, FORTALECE program), PID2021-122348NB-I00, S2022/BMD-7333-CM (INMUNOVAR-CM) and by Generalitat de Catalunya (PERIS-SLT028/23/195 and AGAUR 2021 SGR758), and co-founded by the European Union (FEDER) and “La Caixa” Foundation under the project code LCF/PR/HR22/52420019.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Iron Deficiency Is Associated With Impaired Myocardial Reperfusion in ST‐Segment–Elevation Myocardial Infarction: Influence of the Definition Used

  • Buera Surribas, Irene
  • Mila Pascual, Laia
  • Delgado Tomás, Sara
  • Tobías-Castillo, Pablo Eduardo
  • Barrabés, José A.
  • Inserte, Javier
  • Castellote Bellés, Laura
  • Sambola Ayala, Antonia
  • Uribarri, Aitor
  • Vidal Burdeus, Maria
  • Aluja, David
  • Calvo-Barceló, Maria
  • Guala, Andrea
  • Rodríguez Palomares, José F
  • García del Blanco, Bruno
  • Beneitez Pastor, David
  • Ferreira-Gonzalez, Ignacio
Acute myocardial infarction; Iron deficiency; Reperfusion, Infarto agudo de miocardio; Deficiencia de hierro; Reperfusión, Infart agut de miocardi; Deficiència de ferro; Reperfusió, Background The role of iron deficiency (ID) in ST‐segment–elevation myocardial infarction (STEMI) remains unclear. This study aimed to assess whether ID is associated with impaired myocardial reperfusion in STEMI and whether this association is affected by ID definition. Methods We included 942 consecutive patients with STEMI successfully treated with primary percutaneous coronary intervention. ID was defined either as recommended by international guidelines or, alternatively, as ferritin <100 ng/mL, transferrin saturation <20%, or serum iron ≤13 μmol/L. In 595 patients, serum soluble transferrin receptor levels were measured. Impaired myocardial reperfusion was defined as lack of ST‐segment resolution ≥50% 60 to 90 minutes after percutaneous coronary intervention. Results ID prevalence varied across these definitions. Impaired reperfusion was present in 12.7% of patients without ID and 41.0% of those with ID defined by transferrin saturation <20% (P<0.001). This association was less pronounced for serum iron ≤13 μmol/L, weaker for guideline criteria, and absent for high (≥1.59 mg/L) soluble transferrin receptor levels or low ferritin. Transferrin saturation <20%, but not ferritin‐based criteria, was associated with poorer clinical course and left ventricular function and higher in‐hospital mortality and remained an independent predictor of impaired reperfusion after adjusting for baseline predictors and anemia. Conclusions ID defined by transferrin saturation <20% is strongly related to impaired ST resolution and predicts a worse in‐hospital outcome in patients with STEMI treated with primary percutaneous coronary intervention. The association of other ID criteria with myocardial reperfusion or with the clinical course is weaker or absent. The potential preventive or therapeutic strategies targeting ID in STEMI warrant further investigation., This study was funded by Instituto de Salud Carlos III, Spain, through the projects AES PI16/00232 and AES PI23/00068 and the research network CIBERCV (CB16/11/00479), both co‐funded by European Regional Development Fund, and by the Sociedad Española de Cardiología y Fundación Española del Corazón (SEC/FEC‐INV‐BAS 23/11).
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publicación Artículo científico (JournalArticle)

Iron Deficiency Is Associated With Impaired Myocardial Reperfusion in ST‐Segment–Elevation Myocardial Infarction: Influence of the Definition Used

  • Buera Surribas, Irene
  • Mila Pascual, Laia
  • Delgado Tomás, Sara
  • Tobías-Castillo, Pablo Eduardo
  • Barrabés, José A.
  • Inserte, Javier
  • Castellote Bellés, Laura
  • Sambola Ayala, Antonia
  • Uribarri, Aitor
  • Vidal Burdeus, Maria
  • Aluja, David
  • Calvo-Barceló, Maria
  • Guala, Andrea
  • Rodríguez Palomares, José F
  • García del Blanco, Bruno
  • Beneitez Pastor, David
  • Ferreira-Gonzalez, Ignacio
Acute myocardial infarction; Iron deficiency; Reperfusion, Infarto agudo de miocardio; Deficiencia de hierro; Reperfusión, Infart agut de miocardi; Deficiència de ferro; Reperfusió, Background The role of iron deficiency (ID) in ST‐segment–elevation myocardial infarction (STEMI) remains unclear. This study aimed to assess whether ID is associated with impaired myocardial reperfusion in STEMI and whether this association is affected by ID definition. Methods We included 942 consecutive patients with STEMI successfully treated with primary percutaneous coronary intervention. ID was defined either as recommended by international guidelines or, alternatively, as ferritin <100 ng/mL, transferrin saturation <20%, or serum iron ≤13 μmol/L. In 595 patients, serum soluble transferrin receptor levels were measured. Impaired myocardial reperfusion was defined as lack of ST‐segment resolution ≥50% 60 to 90 minutes after percutaneous coronary intervention. Results ID prevalence varied across these definitions. Impaired reperfusion was present in 12.7% of patients without ID and 41.0% of those with ID defined by transferrin saturation <20% (P<0.001). This association was less pronounced for serum iron ≤13 μmol/L, weaker for guideline criteria, and absent for high (≥1.59 mg/L) soluble transferrin receptor levels or low ferritin. Transferrin saturation <20%, but not ferritin‐based criteria, was associated with poorer clinical course and left ventricular function and higher in‐hospital mortality and remained an independent predictor of impaired reperfusion after adjusting for baseline predictors and anemia. Conclusions ID defined by transferrin saturation <20% is strongly related to impaired ST resolution and predicts a worse in‐hospital outcome in patients with STEMI treated with primary percutaneous coronary intervention. The association of other ID criteria with myocardial reperfusion or with the clinical course is weaker or absent. The potential preventive or therapeutic strategies targeting ID in STEMI warrant further investigation., This study was funded by Instituto de Salud Carlos III, Spain, through the projects AES PI16/00232 and AES PI23/00068 and the research network CIBERCV (CB16/11/00479), both co‐funded by European Regional Development Fund, and by the Sociedad Española de Cardiología y Fundación Española del Corazón (SEC/FEC‐INV‐BAS 23/11).
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publicación Artículo científico (JournalArticle)

Glycative Stress Disrupts the Mitochondrial-Lysosome Axis and Promotes Geroconversion in Aging Cardiomyocytes

  • Valiuška, Simonas
  • Rubeo, Chiara
  • Bonzon-Kulichenko, Elena
  • Nichtova, Zuzana
  • BOU-TEEN, DIANA
  • miro casas, elisabet
  • Inserte, Javier
  • Rodriguez-Sinovas, Antonio
  • Benito, Begoña
  • Ródenas-Alesina, Eduard
  • Ferreira-Gonzalez, Ignacio
  • Ruiz Meana, Marisol
Aging; Cardiomyocytes; Lipofuscin, Envejecimiento; Cardiomiocitos; Lipofuscina, Envelliment; Cardiomiòcits; Lipofuscina, Aging is a major risk factor for heart failure, yet the molecular mechanisms linking cardiac aging to the inflammatory pathophysiology of heart failure remain elusive. Mitochondrial dysfunction and defective organelle quality control are emerging hallmarks of the aging heart, but their biochemical underpinnings are poorly defined. Using comprehensive glycomics, we found that cardiac mitochondria from physiologically aged mice (≥ 20 months) are the major intracellular reservoirs of advanced glycation end products (AGEs), derived primarily from the chemical attack of some α-oxoaldehydes on proteins. This was associated with mild mitochondrial dysfunction and structural remodeling. Lysosomes in aged hearts were enlarged, more abundant, less acidic, and frequently loaded with lipofuscin. Notably, ~7% of cardiomyocytes showed proinflammatory senescence traits. In vitro, glycative stress in H9c2 myoblasts reproduced mitochondrial AGE buildup, dysfunction, and activation of the mitochondria–lysosome axis. However, AGE-modified mitochondria impaired lysosomal acidification and proteolysis, hindering mitophagic clearance and contributing to lipofuscin accumulation. This sequence of events ultimately led to proinflammatory senescence in a subset of cells. These findings identify mitochondrial AGE accumulation as a novel mechanism of sublethal nonsolved aging-associated stress that eventually triggers geroconversion in cardiomyocytes. This mechanism could facilitate the transition of the aging heart towards a failing phenotype., This study was funded by the Instituto de Salud Carlos III of the Spanish Ministry of Health through the projects FIS-PI22-00513, FIS PI23/00068, TACTICS (FORT23/0034, FORTALECE program), PID2021-122348NB-I00, S2022/BMD-7333-CM (INMUNOVAR-CM) and by Generalitat de Catalunya (PERIS-SLT028/23/195 and AGAUR 2021 SGR758), and co-founded by the European Union (FEDER) and “La Caixa” Foundation under the project code LCF/PR/HR22/52420019.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publicación Artículo científico (JournalArticle)

Efficacy of a cysteine protease inhibitor compared with enalapril in murine heart failure models

  • Aluja, David
  • Delgado Tomás, Sara
  • Ferreira González, Ignacio
  • Barrabés, José A.
  • miro casas, elisabet
  • Ruiz Meana, Marisol
  • Rodriguez-Sinovas, Antonio
  • Benito, Begoña
  • Inserte, Javier
Cardiovascular medicine; Cell biology, Medicina cardiovascular; Biologia cel·lular, Medicina cardiovascular; Biología celular, Cysteine proteases calpains contribute to heart failure (HF), but it remains unknown whether their inhibition provides any benefit compared to standard pharmacological treatment for HF. Here, we characterize the pharmacological properties of NPO-2270 (NPO) as a potent inhibitor of cysteine proteases. Then, we describe that acute administration of NPO in rodent models of transient ischemia at the time of reperfusion reduces myocardial infarction, while its chronic oral administration attenuates adverse remodeling and cardiac dysfunction induced by ischemic and non-ischemic pathological stimuli more effectively than enalapril when given at the same dose. Finally, we provide evidence showing that the effects of NPO correlate with calpain inhibition and the preservation of the T-tubule morphology, due at least in part to reduced cleavage of the calpain substrate junctophilin-2. Together, our data highlight the potential of cysteine protease inhibition with NPO as a therapeutic strategy for the treatment of heart failure., This work was funded by Instituto de Salud Carlos III, Spain, through the projects AES PI20/01681 and AES PI23/00068; and the research network CIBERCV (CB16/11/00479), both cofunded by European Regional Development Fund; Sociedad Española de Cardiología (SEC/FEC-INV-BAS 22/013); Fundació la Marató de TV3 (FLMTV3/202321-30-31) and PERIS STL/484/2023. Long-Sheng Song is supported by the National Institutes of Health of USA.